Search Results
Reducing the risk of cardiovascular toxicities when treating hematological malignancies
Cardiac toxicity guidelines in older adults with hematological malignancies
Cardiac Toxicities of Breast Cancer Treatment: Pathophysiology, Prevention, and Treatment
Cardio-oncology guidelines for BTKi toxicities in CLL: how are they used in clinical practice?
Why is it important for cardiologists and hematologists to work closely together?
The importance of cardio-oncology in CLL
Improving the Management of Cardiac Immune-Related Adverse Events in Patients With Cancer
Cardio oncology – Risk Prediction and Surveillance for Cardiotoxicity in Cancer Patients
2022 West Oncology Conference | Hematological Malignancies | High-Grade Myeloid Malignancies
Cardiovascular Recovery in Anthracycline Cardiotoxicity
Reducing Therapy-Related Toxicity in Hodgkin Lymphoma
New Concepts in ADT
